Soo-Jeong Kim, MD

Personal Statement

I am board certified in general psychiatry and in child and adolescent psychiatry and am an Associate Professor of Psychiatry, University of Washington. I am also an attending psychiatrist at Seattle Children’s Hospital and University of Washington Medical Center Adult Autism Clinic, and serve as Medical Director at Seattle Children’s Autism Center.

My clinical and research interest is focused on autism spectrum disorder (ASD) and Prader-Willi syndrome (PWS). My research interest is to identify genetic mechanisms for neurobehavioral challenges in individuals with developmental disorders, with special focus on the chromosome 15q11-q13 region. This particular chromosomal region contains several imprinting genes that express differently based on their parental origin. The abnormality of this region is the major cause for Prader-Willi (PWS) and Angelman syndromes. This region has been also implicated in the pathogenesis of Autism Spectrum Disorder (ASD). My lab is also working on pharmacogenomics for variable individual responses to psychotropics.

Our main strategy is massively parallel sequencing of the region of interest. We utilize the next generation sequencing platform to survey genomic differences across individuals with PWS or ASD. We are currently developing expertise in total RNA sequencing as well as DNA methylation sequencing to determine the effects of psychotropic medications and also to survey the effects of changes in the 15q11-q13 region in the whole genome.

Education

University of Florida Master, 2010
University of Illinois at Chicago Fellowship, 2006
University of Chicago Fellowship, 2005
University of Chicago Residency, 2004
Seoul National Univ., Dentistry Medical education, 1993

Department Affiliations

Other Affiliations

Autism Center
Training Clinic

Recent Publications

Differences in resting-state functional connectivity according to the level of impulsiveness in patients with internet gaming disorder.
(2021 Feb 24)
J Behav Addict
Kim SJ, Kim MK, Shin YB, Kim HE, Kwon JH, Kim JJ

Safety, Pharmacokinetics and Pharmacodynamics of a Next-Generation Subcutaneously Administered Coagulation Factor IX Variant, Dalcinonacog Alfa, in Previously Treated Hemophilia B Patients.
(2021 Feb 4)
J Thromb Haemost
You CW, Hong SB, Kim S, Shin HJ, Kim JS, Han JW, Kim SJ, Kim DY, Lee M, Levy H

Rapid Symptom Improvement in Major Depressive Disorder Using Accelerated Repetitive Transcranial Magnetic Stimulation.
(2021 Feb 28)
Clin Psychopharmacol Neurosci 19(1): 73-83
Kim SJ, Son SJ, Jang M, Kim BH, Hong SJ, Seo L, Choi SW, Seok JH, Noh JS

Schizophrenia-associated dysbindin modulates axonal mitochondrial movement in cooperation with p150glued.
(2021 Jan 18)
Mol Brain 14(1): 14
Suh BK, Lee SA, Park C, Suh Y, Kim SJ, Woo Y, Nhung TTM, Lee SB, Mun DJ, Goo BS, Choi HS, Kim SJ, Park SK

Managing Game-Related Conflict With Parents of Young Adults With Internet Gaming Disorder: Development and Feasibility Study of a Virtual Reality App.
(2021 Jan 18)
JMIR Serious Games 9(1): e22494
Shin YB, Kim JJ, Kim H, Kim SJ, Eom H, Jung YH, Kim E

Show complete publication list »
Edit Profile